The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Living Wage
100 VICTORIA EMBANKMENT, LONDON, EC4Y 0DH, ENGLAND
Tel:
Work 020 7400 8000
Fax:
Fax 020 7400 8050
DX:
269 LONDON CHANCERY LANE WC2
Email:
Web:
www.bristows.com

Marek Petecki

Tel:
Work 020 7400 8442
Email:
Web:
www.bristows.com
Bristows LLP

Work Department

Corporate

Position

Marek advises on corporate and commercial transactions in the life sciences, technology and consumer products sectors.

He has particular expertise in mergers and acquisitions, debt and equity financings, joint ventures and collaboration arrangements.

Marek acts for UK and international businesses at all stages of their development, including growth companies and FTSE 100 companies. He also advises venture capital and private equity investors focussed on IP-rich sectors, and has extensive experience of corporate venture capital transactions.

Career

Trained Clifford Chance; qualified 2003; associate Clifford Chance 2003-04; associate Slaughter and May 2004-10; associate Bristows 2010; partner Bristows 2010 to date.

Languages

French

Education

Manchester Grammar School; University College London (1998 BA History and Anthropology)

Leisure

Family, running, cycling


London: Corporate and commercial

M&A: smaller deals up to £50m

Within: M&A: smaller deals up to £50m

The life sciences and technology sectors are particular areas of focus for the team at Bristows LLP, which regularly acts for large multinationals. Joint managing partner Marek Petecki advised AstraZeneca on the $300m sale of the European commercial rights to its Seloken heart medicines, as well as on the disposal of its early-stage rare disease drugs; Louise Eldridge acted for Ferroglobe on its acquisition of manganese alloy plants in France and Norway from Glencore; and practice head Iain Redford assisted WPP with the £60m acquisition of Design Bridge. The team is also noted for its work for early-stage growth businesses, entrepreneurs and SMEs: recent highlights include Mark Hawes advising UK biotech NuCana on the UK aspects of its $114m IPO of American depositary shares on NASDAQ, and Matt Dennis acting for OXIS Energy, a battery cell company, on four financing rounds. Key clients include Diageo, Cronin, Canon and Amazon. Of counsel David Horner is also noted.

[back to top]

London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

The 'excellent' and 'client-focused' Bristows LLP has a strong reputation in patent litigation, but also works on matters involving transactions, regulations and competition. The practice is headed by patent litigator Liz Cohen and transactions specialist Laura Anderson. Brian Cordery is head of patent litigation and very active in this space. He was instructed by Teva in patent revocation proceedings brought by Eli Lilly relating to humanised antibodies, which may be used for a landmark treatment of migraines. Other important  contentious IP specialists include Edward Nodder, Robert Burrows and Dominic Adair. Burrows defended Janssen Sciences and G.D. Searle against a revocation brought by Sandoz and Hexal relating to darunavir, which is a key ingredient in Janssen's anti-HIV drug Prezista. Also recommended are corporate specialist Marek Petecki, who assisted AstraZeneca with its $300m sale of the European commercial rights to its Seloken heart medication to Recordati, and senior associate Rachel Mumby, who focuses on patent litigation.

[back to top]


Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to